Andrea Lauber
About Andrea Lauber
Andrea Lauber is the Global Head of Transactions for Pharmacodiagnostics and Clinical Biomarkers at Bristol-Myers Squibb, specializing in structuring deals and collaborations for diagnostic products.
Title
Andrea Lauber currently holds the position of Global Head of Transactions for Pharmacodiagnostics and Clinical Biomarkers.
Company
Andrea Lauber is currently employed at Bristol-myers Squibb, operating in the role of Global Head of Transactions for Pharmacodiagnostics and Clinical Biomarkers, based in New Jersey, United States.
Education and Expertise
Andrea Lauber obtained her Doctor of Philosophy in Neuroscience from the University of California, Riverside, a program she completed over the span of six years from 1981 to 1987. Her expertise includes structuring deals and collaborations specifically tailored for the development and commercialization of diagnostic products. She holds extensive experience in negotiations and closing transactions related to diagnostics and biomarkers.
Background
Before her current role at Bristol-myers Squibb, Andrea Lauber served as the Chief Business Development Officer at Broad Institute in Cambridge, Massachusetts, from 2005 to 2006. Prior to that, she was the Executive Director, Head of Strategic Alliances at Novartis in Basel, Switzerland, from 2003 to 2004. Earlier in her career, she also held the position of Director of External Science Technology and Licensing at Bristol-myers Squibb from 2000 to 2003.
Achievements
Andrea Lauber has been instrumental in leading the strategy for external partnering activities at Bristol-Myers Squibb for over 16 years. Specializing in companion products that support therapeutic assets, she provides critical business development support specifically for Pharmacodiagnostics and Clinical Biomarkers.